SerpApi.Org
Millions of aerosol sunscreen cans from some of the best-known brands in the United States have been pulled from shelves after internal company testing found low levels of benzene, a chemical the federal government classifies as a known human carcinogen. Johnson & Johnson Consumer Inc. voluntarily recalled specific Neutrogena and Aveeno aerosol sunscreen products, and Coppertone followed with its own nationwide recall covering multiple SPF 50 spray lots. The recalls, carried out with FDA knowledge, have forced consumers into an uncomfortable calculation: how to protect skin from ultraviolet radiation without risking exposure to a contaminant linked to leukemia and other blood cancers.
Why benzene in aerosol sunscreens demands attention right now
The core problem is not the UV-blocking ingredients themselves. Benzene is not an intentional sunscreen ingredient. It enters finished products through manufacturing and supply-chain decisions, particularly through certain excipients called carbomers. The FDA’s Center for Drug Evaluation and Research published guidance explaining how carbomers manufactured with benzene can carry the contaminant into drug products, including topical sprays. That distinction matters because the same active UV filters used in lotions and sticks can test clean for benzene while an aerosol version of the same brand shows contamination. The delivery format and its associated manufacturing chemistry, not the sun-protection chemistry, appear to be the weak link.
Aerosol sunscreens add a second risk pathway that lotions do not: inhalation. When a consumer sprays an aerosol product, fine droplets enter the breathing zone. The FDA has stated that benzene exposure through inhalation, oral intake, or skin absorption is tied to cancer risk, including leukemia and other blood disorders. For a product designed to be applied liberally and reapplied every two hours during outdoor activity, even low-level contamination can translate into repeated exposures over a single summer.
Dermatologists and toxicologists stress that benzene is a ubiquitous industrial chemical, and background exposure occurs through sources like gasoline fumes and cigarette smoke. The concern with contaminated consumer products is not that a single use will trigger disease, but that preventable, repeated exposures are being added to an already crowded risk profile. When a product is marketed for daily use on children and adults, regulators tend to apply a lower tolerance for contaminants with well-established links to cancer.
Recalls from Johnson & Johnson and Coppertone trace the same flaw
Johnson & Johnson Consumer Inc. recalled specific aerosols after internal testing detected low levels of benzene. The recall notice, posted on the FDA’s safety-alerts page, instructed consumers to stop using the products, discard them, and seek refunds. The agency confirmed that the action took place with its knowledge, underscoring that the products no longer met the standard for acceptable impurity levels in over-the-counter drugs.
Coppertone issued a separate voluntary nationwide recall covering specific lots of its Pure and Simple SPF 50 Spray, Sport Mineral SPF 50 Spray, and a travel-size Coppertone Sport Spray SPF 50 aerosol, all from 2021 launches. The FDA has since noted that the Coppertone benzene recall has been completed and terminated, meaning the affected lots are no longer expected to be in distribution. The fact that two separate manufacturers, using different formulations and supply chains, triggered recalls for the same contaminant points to a systemic vulnerability in how aerosol sunscreens are produced rather than an isolated quality-control failure at one factory.
Independent researchers reached similar conclusions through their own laboratory work. A peer-reviewed screening study published in Environmental Health Perspectives documented benzene contamination across multiple sun care products, with aerosol sprays disproportionately represented among the positive findings. That independent testing helped trigger the wave of recalls, connecting outside laboratory results to corporate and regulatory action. The CDC’s Yellow Book, the agency’s travel-medicine reference now in its 2026 edition, lists manufacturing-related contamination including benzene as a documented sunscreen risk, placing the issue squarely within federal public-health guidance and not just in the realm of consumer advocacy.
Gaps in testing and the consumer trade-off ahead
Several questions remain open. Neither the FDA recall notices nor the company announcements have disclosed exact batch-level benzene concentrations verified by independent federal laboratories. The recalls relied on internal company testing, and no public data set shows how many contaminated units reached consumers before the products were pulled. Without that information, it is difficult for public-health researchers to estimate cumulative exposure across the population that used these sprays during peak summer months.
The FDA has also not published details on any ongoing or planned testing protocol for aerosol sunscreen products that remain on store shelves from other manufacturers. The agency’s benzene contamination FAQ tells consumers not to use recalled products and to continue practicing sun safety with alternative options, but it does not specify how the remaining aerosol market is being monitored for the same contamination pathway. That leaves consumers and clinicians relying on company assurances and sporadic third-party testing instead of a transparent, routine federal screening program.
The practical dilemma for consumers is real. Aerosol sunscreens are popular precisely because they are easy to apply, especially on children and on hard-to-reach areas of the body. Abandoning them entirely could mean less consistent sun protection, which carries its own well-documented cancer risk from UV exposure. The FDA has been careful to say that people should continue protecting themselves from the sun while avoiding only the specific products and lots identified in recalls. Still, the absence of clear, product-by-product benzene data makes it hard for families to know whether to trust aerosol formats at all or to switch entirely to lotions, creams, and sticks until manufacturing controls improve.
For now, public-health experts tend to frame the decision as a risk hierarchy. At the top is the need to prevent sunburns and cumulative UV damage, which drive skin cancers including melanoma. Within that priority, consumers can reduce avoidable chemical exposures by favoring non-aerosol sunscreens, checking recall lists before purchasing sprays, and using aerosol products outdoors in well-ventilated areas when they are the only practical option. Parents of children with sensitive skin or chronic health conditions may opt for mineral-based lotions, which have not been implicated in benzene contamination and avoid the inhalation route altogether.
What regulators and manufacturers could do next
The benzene findings in aerosol sunscreens highlight a broader regulatory challenge: how to manage impurities that enter over-the-counter drugs through complex global supply chains. FDA guidance on carbomer manufacturing has already signaled to ingredient suppliers that benzene-based processes are under scrutiny, but implementation across factories and contract manufacturers will take time. Stronger requirements for impurity testing of finished aerosol products, rather than relying solely on raw-material certificates, could catch problems before millions of cans are shipped.
Manufacturers, for their part, can redesign formulations to avoid excipients with known benzene-associated production routes, audit contract facilities more aggressively, and publish summary impurity data to rebuild consumer trust. Clearer labeling about the type of dispenser-continuous spray versus pump, for example-could also help consumers understand when inhalation exposure is more likely and adjust how they apply the product. Some companies have already begun emphasizing non-aerosol formats in new product launches, a shift that could accelerate if retailers and insurers start favoring lower-risk delivery systems.
Ultimately, the benzene recalls are a reminder that even products designed to prevent one form of cancer can inadvertently introduce another risk if manufacturing shortcuts or outdated processes go unchecked. Until regulators provide more comprehensive testing data and manufacturers close the gaps that allowed benzene into aerosol sunscreens, consumers are left to navigate an imperfect set of choices. Favoring lotions and sticks, applying them generously, and reserving aerosols for situations where no alternative is practical may offer the most balanced path between sun safety and chemical exposure in the summers ahead.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
